-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Sio Gene Therapies Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to 2021.
- Sio Gene Therapies Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $0.000.
- Sio Gene Therapies Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2022 was $283K, a 342% increase year-over-year.
- Sio Gene Therapies Inc. annual Income Tax Expense (Benefit) for 2021 was $259K.
- Sio Gene Therapies Inc. annual Income Tax Expense (Benefit) for 2020 was -$212K, a 148% decline from 2019.
- Sio Gene Therapies Inc. annual Income Tax Expense (Benefit) for 2019 was $438K, a 229% increase from 2018.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)